Stage IV Sinonasal Cancer AJCC v8

general

Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Nasal cavity and ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fos

22

Centers

27

Active Trials

Cancer Funding

Top Centers for Stage IV Sinonasal Cancer AJCC v8(22)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.8
2
NCI Comprehensive
High-Volume Research Center
70.7
3
High-Volume Research Center
70.7
4
NCI Comprehensive
Active Research Program
49.2
5
NCI Comprehensive
Active Research Program
49.2
6
NCI Comprehensive
Active Research Program
49.2
7
NCI Comprehensive
Active Research Program
49.2
8
NCI Comprehensive
Active Research Program
49.2
9
NCI Comprehensive
Active Research Program
49.2
10
NCI Comprehensive
Active Research Program
49.2
11
NCI Comprehensive
Active Research Program
49.2
12
NCI Comprehensive
Active Research Program
49.2
13
NCI Clinical
Active Research Program
49.2
14
NCI Comprehensive
Active Research Program
49.2
15
Active Research Program
49.2
16
NCI Comprehensive
Active Research Program
49.2
17
NCI Comprehensive
Active Research Program
49.2
18
NCI Clinical
Active Research Program
49.2
19
NCI Comprehensive
Active Research Program
49.2
20
Active Research Program
49.2
21
Active Research Program
49.2
22
Active Research Program
49.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →